References
- Patel MM , GoyalBR, BhadadaSVet al. Getting into the brain: approaches to enhance brain drug delivery. CNS Drugs 23(1), 35–58 (2009).
- Sarkar S , DasN. Mannosylated liposomal flavonoid in combating age-related ischemia-reperfusion induced oxidative damage in rat brain. Mech. Ageing Dev.127(4), 391–397 (2006).
- Ying X , WenH, LuWLet al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J. Control. Release 141(2), 183–192 (2010).
- Mitra M , MandalAK, ChatterjeeTKet al. Targeting of mannosylated liposome incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticuloendothelial systems for the treatment of visceral leishmaniasis. J. Drug Target. 13(5), 285–293 (2005).
- Liu Y , LuWL, GuoJet al. A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes. J. Control. Release 129(1), 18–25 (2008).
- Hao ZF , CuiYX, LiMHet al. Liposomes modified with p-aminophenyl-α-D-mannopyranoside: a carrier for targeting cerebral functional regions in mice. Eur. J. Pharm. Biopharm. 84(3), 505–516 (2013).
- Tsuji A . Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems. NeuroRx2, 54–62 (2005).
- Dick AP , HarikSI, KlipAet al. Identification and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunological reactivity. Proc. Natl Acad. Sci. 81(22), 7 (1984).
- Klepper J , FischbargJ, VeraJC, et al. GLUT1-deficiency: barbiturates potentiate haploinsufficiency in vitro. Pediatr. Res.46(6), 677–683 (1999).
- Lagrue E , AbeH, LavanyaMet al. Regional characterization of energy metabolism in the brain of normal and MPTP-intoxicated mice using new markers of glucose and phosphate transport. J. Biomed. Sci. 17, 91 (2010).